A brand new report from New Frontier Data explores the need of understanding what medical hashish sufferers are at present on the lookout for and require in hashish medication. Entitled “From Doctor to Dispensary: A Complete Picture of Medical Cannabis Consumers,” the report analyzes information from a not too long ago printed consumer survey, which incorporates enter from 1,874 medical hashish sufferers.
New Frontier Information argues that insurance coverage firms may benefit essentially the most from higher understanding medical sufferers. “The Federal Schedule 1 standing of hashish implies that it has no acknowledged medical worth. On the similar time, virtually each state within the U.S. permits for some type of medical hashish use,” the report states. “This contradiction has resulted in thousands and thousands of medical hashish sufferers with the approval to make use of hashish by their state and their physician, however no entry to insurance coverage reimbursement for this medication, which is normally extremely taxed.”
Among the many commonest circumstances that medical sufferers deal with with hashish is pain (47% of surveyed individuals), adopted by nervousness/panic assaults (22%), despair (9%), sleep problems (9%), PTSD (7%), neurological problems (6%). Moreover, 93% of medical hashish customers say that hashish has helped them, with 57% saying that it considerably improved their medical circumstances (whereas solely 36% say that it solely barely improved their situation).
Fifty % of sufferers reported that they have been at present utilizing prescribed drugs, primarily antidepressants (45%), muscle relaxers (27%), arthritis (23%), sleep (20%), and opioids for ache (17%). Over half of the sufferers additionally stated that they’ve changed some or all of their prescription drugs with hashish as nicely.
The federally unlawful standing of hashish is a roadblock for a lot of elements of the trade, however opinions about hashish are quickly altering. “This data is particularly helpful to insurance coverage firms who would possibly view hashish as a drugs with much less potential hurt and due to this fact much less value to them than different drugs,” the report explained. “Much less hurt can also be a driver for the medical hashish shopper as solely 40% say that saving cash is a purpose for the substitution.”
New Frontier Information additionally advises how manufacturers can finest cater to medical hashish sufferers versus common leisure customers. Each medical and leisure customers choose to eat hashish on their very own, or with out others. In merchandise with a hybrid of cannabinoid content material, solely 43% of medical customers selected merchandise with extra THC than CBD, in comparison with 57% of leisure customers. Nevertheless, medical hashish customers led with 54% for merchandise that had “barely extra CBD than THC,” and 57% with merchandise that contained “far more CBD than THC.”
General, the report discovered that 55% of medical customers consider it’s essential to contemplate minor cannabinoids or terpenes when making a purchase order (with 23% saying “I don’t know what that’s.”)
Retailers additionally stand to replace their method to serving medical hashish sufferers, as they normally have sturdy loyalty to strains that they know are efficient. Fifty-nine % normally or all the time choose the identical pressure, whereas solely 34% will alternate between choices they’re acquainted with. Most customers, each medical (52%) and leisure (50%), are inclined to spend round $50-$200 on hashish merchandise monthly, whereas a decrease share will spend greater than $200 (30% for medical and 33% for leisure).
“With all of the give attention to grownup use legalization and the leisure shopper, it may be simple to neglect that there’s a massive inhabitants of customers who depend on hashish for his or her bodily and psychological well being,” the report concluded. “And whereas some might argue that each one hashish use is medical, there are actually distinguishing elements for medical customers as evidenced above. As hashish continues its march in direction of federal medical acceptance, insurance coverage firms, manufacturers and retailers ought to concentrate on the wants of this group and how one can meet them.”